Disclosures for "A Predictive Model for Triple Negative Optic Neuritis Patients: Identifying the Subset of Patients With Favorable Outcomes"
-
Ariel Rechtman has nothing to disclose.
-
Dr. Friedman Korn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
-
Mr. Zveik has nothing to disclose.
-
Dr. Zamir has nothing to disclose.
-
Dr. Levin has nothing to disclose.
-
Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for neopharm group. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for medisone . Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion.